Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,990,227
+$15,565,493 QoQ
Shares Held
1,477,838
+94.6% QoQ
Ownership
0.978%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 294 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Jun 30, 2024CallValue
$208,260
CallShares
6,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. BHVN ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in BHVN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,990,227 | 1,477,838 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,424,734 | 759,425 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $20,236,678 | 1,792,443 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,832,845 | 788,331 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $5,933,267 | 420,501 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,920,857 | 371,084 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,599,378 | 310,559 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,042,519 | 220,983 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,184,873 | 552,719 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $208,260 | 6,000 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $8,969,160 | 164,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $9,909,552 | 181,195 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,777,291 | 111,619 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,439,825 | 324,484 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,653,967 | 194,564 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,526,107 | 770,579 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,425,162 | 390,862 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||